Inventor
ARMER THOMAS
US22 patents
⚠️ This page may combine multiple inventors who share the name “ARMER THOMAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
XOC PHARMACEUTICALS INC
12 patentsUS9657020B2May 23, 2017
Ergoline compounds and uses thereof
XOC PHARMACEUTICALS INC10 citations91
US9815830B2Nov 14, 2017
Isoergoline compounds and uses thereof
XOC PHARMACEUTICALS INC6 citations83
US9777016B2Oct 3, 2017
Isoergoline compounds and uses thereof
XOC PHARMACEUTICALS INC6 citations83
US9676776B2Jun 13, 2017
Isoergoline compounds and uses thereof
XOC PHARMACEUTICALS INC6 citations83
US10308651B2Jun 4, 2019
Ergoline compounds and uses thereof
XOC PHARMACEUTICALS INC3 citations82
US10246458B2Apr 2, 2019
Ergoline compounds and uses thereof
XOC PHARMACEUTICALS INC3 citations82
US9951070B2Apr 24, 2018
Ergoline compounds and uses thereof
XOC PHARMACEUTICALS INC6 citations82
US9938277B2Apr 10, 2018
Ergoline compounds and uses thereof
XOC PHARMACEUTICALS INC7 citations82
US10301311B2May 28, 2019
Polycyclic compounds and uses thereof
XOC PHARMACEUTICALS INC3 citations72
US10464936B2Nov 5, 2019
Ergoline compounds and uses thereof
XOC PHARMACEUTICALS INC1 citations71
US10703753B2Jul 7, 2020
Ergoline compounds and uses thereof
XOC PHARMACEUTICALS INC1 citations66
US10815235B2Oct 27, 2020
Polycyclic compounds and uses thereof
XOC PHARMACEUTICALS INC0 citations51
AI THERAPEUTICS INC
4 patentsUS11491143B2Nov 8, 2022
Inhalable rapamycin formulation for the treatment of pulmonary hypertension
AI THERAPEUTICS INC3 citations73
US11103449B2Aug 31, 2021
Inhalable rapamycin formulation for treating age-related conditions
AI THERAPEUTICS INC4 citations73
US10307371B2Jun 4, 2019
Rapamycin for the treatment of lymphangioleiomyomatosis
AI THERAPEUTICS INC6 citations73
US11648199B2May 16, 2023
Inhalable rapamycin formulation for treating age-related conditions
AI THERAPEUTICS INC1 citations62